BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2167049)

  • 41. Production of monoclonal antibody to bovine leukemia virus glycoprotein gp51 by in vitro immunization.
    Sasaki O; Tanaka M; Okabe T; Imanishi J
    Microbiol Immunol; 1990; 34(4):401-5. PubMed ID: 2163485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The diagnosis of enzootic bovine leukosis.
    Mammerickx M; Portetelle D; Burny A
    Comp Immunol Microbiol Infect Dis; 1985; 8(3-4):305-9. PubMed ID: 3004804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of monoclonal antibody in an ELISA test for the detection of antibodies to bovine leukaemia virus.
    Portetelle D; Bruck C; Mammerickx M; Burny A
    J Virol Methods; 1983 Jan; 6(1):19-29. PubMed ID: 6300156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agar gel immunodiffusion analysis using baculovirus-expressed recombinant bovine leukemia virus envelope glycoprotein (gp51/gp30(T-)).
    Lim SI; Jeong W; Tark DS; Yang DK; Kweon CH
    J Vet Sci; 2009 Dec; 10(4):331-6. PubMed ID: 19934599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability.
    Bruck C; Rensonnet N; Portetelle D; Cleuter Y; Mammerickx M; Burny A; Mamoun R; Guillemain B; van der Maaten MJ; Ghysdael J
    Virology; 1984 Jul; 136(1):20-31. PubMed ID: 6204449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
    Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
    Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterogeneous properties of BLV-precipitating immunoglobulins in bovine leukemic sera.
    Matthaeus W
    Ann Rech Vet; 1978; 9(4):635-41. PubMed ID: 224758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bovine leukemia virus-specific antibodies in French cattle. III. Prevalence of the BLV-gp 51 radioimmunoassay for the detection of BLV-infected animals.
    Levy D; Deshayes L; Parodi AL; Levy JP
    Int J Cancer; 1980 Jan; 25(1):147-52. PubMed ID: 6249762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the commercial agar-gel immunodiffusion test and radioimmunoprecipitation assay for detection of antibodies to bovine leukemia virus.
    Jacobsen KL; Kaneene JB; Miller JM; Bull RW
    Am J Vet Res; 1985 Jul; 46(7):1430-3. PubMed ID: 2992324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Enzyme immunoassay for the determination of antibodies against bovine leukosis virus].
    Meyer U; Schilow WF
    Arch Exp Veterinarmed; 1984 Mar; 38(2):219-22. PubMed ID: 6331334
    [No Abstract]   [Full Text] [Related]  

  • 51. [Purification of the 2 major antigens of bovine leukosis virus for the purpose of immunoenzymatic detection of antibodies to this virus].
    Maris P; Girre L
    Ann Pharm Fr; 1984; 42(1):57-67. PubMed ID: 6091519
    [No Abstract]   [Full Text] [Related]  

  • 52. Bovine monoclonal antibody to bovine leukemia virus glycoprotein GP51 from bovine-murine hybridoma.
    Tanaka M; Okabe T; Sasaki N
    Nihon Juigaku Zasshi; 1988 Oct; 50(5):1136-8. PubMed ID: 2848966
    [No Abstract]   [Full Text] [Related]  

  • 53. Sensitivity and specificity of a modified agar gel precipitation test and its application to the diagnosis of enzootic bovine leukosis.
    Wawrzkiewicz J; Dziedzic B; Kozioł T
    Acta Virol; 1989 Mar; 33(2):143-50. PubMed ID: 2569810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Production of gp 51 of bovine leukosis virus in tumor tissue cells without lysis of cells by cytotoxic antibodies against gp 51].
    Ristau E; Weppe C
    Arch Exp Veterinarmed; 1984 Sep; 38(5):722-8. PubMed ID: 6099108
    [No Abstract]   [Full Text] [Related]  

  • 55. Detection of antibodies to bovine leukemia virus in bovine milk samples with an ELISA involving two monoclonal antibodies.
    Florent G; Delgoffe JC; Zygraich N
    Vet Microbiol; 1988 Sep; 18(1):89-93. PubMed ID: 2847403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51.
    Bruck C; Mathot S; Portetelle D; Berte C; Franssen JD; Herion P; Burny A
    Virology; 1982 Oct; 122(2):342-52. PubMed ID: 6183819
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthesis of bovine leukemia virus antigens in Escherichia coli.
    Ulrich R; Siakkou H; Platzer C; Bossmann H; Möhring R; Wiedmann M; Bähring S; Rosenthal S
    Arch Exp Veterinarmed; 1990; 44(6):909-16. PubMed ID: 1966363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bovine leukemia virus-gp51 antigen expression is associated with CD5 and IgM markers on infected lymphocytes.
    Meirom R; Moss S; Brenner J
    Vet Immunol Immunopathol; 1997 Oct; 59(1-2):113-9. PubMed ID: 9437829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of radioimmunoassay for internal protein of bovine leukemia virus with neutralization test employing VSV-BLV pseudotype.
    Zajac V; Altaner C; Závada J; Cerný L
    Neoplasma; 1980; 27(5):517-23. PubMed ID: 6262669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunohistological demonstration of virus and tumor associated antigens in tissues experimental and spontaneous bovine leukemia virus (BLV) infection.
    Reinacher M; Thurmond MC; Onuma M; Portetelle D; Picanso J; Theilen GH
    Vet Immunol Immunopathol; 1989 Oct; 22(3):223-31. PubMed ID: 2560854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.